Comment on

• RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study.

  Lorenz B, Stieger K, Jäger M, Mais C, Stieger S, Andrassi-Darida M. Lorenz B, et al. Retina. 2017 Jan;37(1):97-111. doi: 10.1097/IAE.0000000000001126. Retina. 2017. PMID: 27454223
• Correspondence.

  Martínez-Castellanos MA, Cernichiaro-Espinosa LA. Martínez-Castellanos MA, et al. Retina. 2018 Aug;38(8):e64-e65. doi: 10.1097/IAE.0000000000002229. Retina. 2018. PMID: 29923884 No abstract available.